The Hippo/YAP signaling pathway: the driver of cancer metastasis

Tianxing Zhou; Xueyang Li; Jing Liu; Jihui Hao

doi:10.20892/j.issn.2095-3941.2023.0164

The Hippo/YAP signaling pathway: the driver of cancer metastasis

Cancer Biol Med. 2023 Jul 11;20(7):483-489. doi: 10.20892/j.issn.2095-3941.2023.0164.

Authors

Tianxing Zhou¹, Xueyang Li^{1

2}, Jing Liu^{1

2}, Jihui Hao¹

Affiliations

¹ Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
² Department of Breast Oncoplastic Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China.

PMID: 37493303
PMCID: PMC10466436
DOI: 10.20892/j.issn.2095-3941.2023.0164

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Hippo Signaling Pathway
Humans
Neoplasms*
Signal Transduction

Grants and funding

This work was supported by the National Key Research and Development Program of China (2021YFA1201100), National Natural Science Foundation of China (Grant Nos. 82072716, 81802433, 82030092, 81720108028, 82072657, 82072659, 82173295, 81871968, 81871978, and 82103006), Tianjin Natural Science Foundation (Grant No. 20JCQNJC01330), Collaboration Program of Beijing Tianjin and Hebei (Grant No. 22JCZXJC00120), and Tianjin Research Innovation Project for Postgraduate Students (Grant No. 2021YJSB262).